Ross\Johnson & Associates’s Merck MRK Stock Holding History

Ross\Johnson & Associates’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.89K	Sell	24 -3	-11%	-$346	0.05%	63
2025 Q4	$2.84K	Sell	27 -21	-44%	-$1.97K	0.05%	63
2025 Q3	$4.03K	Buy	48 +24	+100%	+$1.98K	0.08%	54
2025 Q2	$1.9K	Sell	24 -617	-96%	-$49K	0.04%	66
2025 Q1	$57.5K	Buy	641 +18	+3%	+$1.68K	0.99%	15
2024 Q4	$62K	Buy	+623	New	+$64.2K	1.43%	8

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ross\Johnson & Associates's MRK Position: Q1 2026 in Review

Ross\Johnson & Associates reduced its Merck (MRK) stake by 11% in Q1 2026, selling an estimated $346 and leaving 24 shares worth $2.89K. The position accounts for 0.05% of the portfolio, ranked #63.

Ross\Johnson & Associates first reported a position in MRK in Q4 2024 and has held it in 6 quarters since. The position peaked at $62K in Q4 2024. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Ross\Johnson & Associates held 24 shares of Merck worth $2.89K as of Q1 2026.
Ross\Johnson & Associates sold 3 Merck shares in Q1 2026, an estimated $346.
Merck made up 0.05% of Ross\Johnson & Associates's portfolio in Q1 2026, its #63 holding.
Ross\Johnson & Associates first reported a position in Merck in Q4 2024 and has held it in 6 quarters since.
Ross\Johnson & Associates's Merck position peaked at $62K in Q4 2024.
3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Ross\Johnson & Associates's 13F filing for Q1 2026, filed 8 May 2026.